12:00 AM
 | 
Jan 28, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

BioPorto Diagnostics, Siemens sales and marketing update

BioPorto received notification from Siemens that it halted sale activities concerning BioPorto's NGAL Test to diagnose acute kidney injury. BioPorto said that Siemens will refer customers to BioPorto. The company also...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >